Determination of aluminum abundance in brain tissues using electrothermal atomic-absorption spectrometry (ETAAS) -Tissues were harvested under RNAse-free clean conditions and were subjected to Zeeman-type ETAAS trace metal analysis for aluminum typically most tissue samples were 0.5 gm wet weight. All human tissues, chemicals and reagents, protein extraction and quality control and all analytical and ultrapure chemicals and reagents used in these experiments were obtained from standard commercial suppliers; all chemicals and reagents were used in accordance with the manufacturer's specifications and without any additional purification. 
'dry' ashed in platinum mini-crucibles, taken up in concentrated ultrapure HNO 3 (OmniTrace UltraTM Nitric acid NX0408, EMD Merck-Millipore, or ULTREX II Ultrapure Reagent, JT Baker/VWR Radnor PA, USA; aluminum content ~20 ppt) and subjected to ETAAS as previously described by our laboratory and others. Parallel sets of samples were also analyzed using the 'wet'-digestion method of Trapp et al (1978) and Van der Voet (1985) as modified by van Ginkel et al., (1990) [S1-S3] . In the later method 0.5 gm samples of tissue in disposable polypropylene or Teflon tubes were incubated 24 hr at 45 o C in 0.8 mL concentrated ultrapure nitric acid and 0.2 ml concentrated ultrapure sulfuric acid (ULTREX II Ultrapure Reagent, J.T.Baker/VWR Radnor PA, USA; aluminum content <50 ppt) in a dedicated 24 position thermomixer/extractor device (Eppendorf model 5436; Eppendorf Inc, Hauppauge NY, USA) with constant agitation; the temperature was next raised to 70 o C for 3 hrs and then 105 o C resulting in a clear yellow solution, diluted up to 3.0 ml with ultrapure water and subjected to trace metal analysis. The use of a dedicated thermomixer device with constant agitation at elevated temperature ensured a thorough concentrated acid-based dissolution of the sample (as suggested by the manufacturer of OmniTrace UltraTM acids; such as Nitric acid NX0408, EMD Merck-Millipore). In either sample hysdrolysis method there was no particulate matter visible in the hydrolysate solution. All sample tubes were spun briefly in a table top microfuge to make sure all liquid in the vial was drained from the seal and the sides of the walls of the analytical tubes prior to analysis.
Analytical Parameters, controls and independent analysis -Trace metal analysis was performed in triplicate or quadruplicate on 20 uL samples using electrothermal atomic absorption spectrophotometry (ETAAS); PE5000PC system, Zeeman-type, Perkin-Elmer, Waltham MA, USA) equipped with an PE automated sampler (18 and 24 position autosampler; aluminum detection limit ~2.2 ng/mL) and an IBM/AT supported analysis package for trace metal analysis, as previously described by our group and others. For multiple sample analyses data were obtained as 'relative signal strength' of aluminum abundance to a standard, or aluminum expressed as ng/gm or ug/gm wet weight of tissue. The ETAAS device hollow-cathode lamp was operated at 15 mA; atomic absorption for aluminum was measured at 309.3 nm with a spectral band width of 0.7 nm; the purge gas was Argon at 300 ml/min gas flow; gas flow was interrupted at atomization; typically the dry cycle was 130 o C, 10 sec ramp, 5 sec hold; char cycle 1500 o C, 18
sec ramp with a 6 sec hold; the atomize cycle was 2700 o C with a 0 sec ramp and a 6 sec hold, although other programs were used with quantitatively similar results; aluminum concentrations in the digest were determined using the standard addition method. In the later a 10 mg/L aluminum aqueous solution was prepared from ultrapure reagents; aqueous standard solutions of 0, 10, 20 and 50 ug/L were prepared; typically a 250 uL sample of digest was mixed with an equal volume of standard solution prior to analysis in duplicate; the detection limit of this assay was about 5.0 ng aluminum/gm wet weight of tissue. Some samples were also analyzed using an X-ray-fluorescence raster-scanning (XRFR) spectroscopy device at the advanced photon source (APS) facility at Argonne National Preliminary Findings using the XRFR method: This novel analytical technique is still under development and the use of the APS facility is highly restricted to qualified scientific, medical and military researchers. To date our group has focused on the analysis of Alzheimer (AD; N=3; mean age 74.5+/-8.4 yrs) and control (no neurological disease; N=3; mean age 73.8+/-7.5 yrs) tissue samples. As indicated above; this technology is capable of detecting Al, P, S, Cl, K, Ca, Fe and Zn nondestructively in ultra-thin-10-um-sections of human-brain tissue samples in extremely complex biological-samples (see Figure S4 -3 to S4-5 above); each ultra-thin-10-um-sectioned human-brain tissue sample is typically scanned in triplicate; ~3.8 million separate-elemental-analyses were achieved in a ~4-day experiment; to date we have collected about 7x10 9 data points amenable to ongoing bioinformatics and biostatistical analysis; in agreement with the ETAAS results these preliminary data indicate that using XRFR we have found a major increase in aluminum in AD brain to approximately 5-9-fold over age-matched control and the results are highly significant (p<000.1 (ANOVA); see also Table 1 ).
